NetScientific appoints Prof. Stephen Smith as NED

RNS Number : 2646P

NetScientific PLC

17 February 2016

 

NetScientific plc

NetScientific appoints Professor Stephen Smith as Non-Executive Director

London, UK - 17 February 2016 - NetScientific plc ("NetScientific" or the "Group", AIM: NSCI), the transatlantic biomedical and healthcare technology group, appoints Professor Stephen Smith as Non-Executive Director, with effect from today. Professor Smith will also join both the audit and remuneration committees.

Stephen has held senior leadership roles in the NHS and academia. He has had a long and distinguished career as a clinician scientist, Head of Department, Dean and CEO with the Medical Research Council, University of Cambridge, Imperial College, London and Imperial College Healthcare NHS Trust.

He was responsible for the largest merger in the NHS, the creation of the UK's first Academic Health Science Centre in 2007. The merger brought together four London based NHS Trusts and ultimately led to the creation of Imperial College Healthcare NHS Trust, where Stephen served for four years as the first CEO. He also retained his position as Dean of the Faculty of Medicine at Imperial College, London and was responsible for facilitating the commercialisation of life sciences and healthcare.

During his career, Stephen has spun two companies out of Cambridge - Metris Therapeutics Ltd and GNI Group Ltd. GNI was established as a start up in Japan in 2001 and successfully achieved an Initial Public Offering (IPO) on the Tokyo Stock Exchange six years later. 

Stephen has extensive non-executive experience serving on the Boards of the National Healthcare Group Singapore which developed integrated care through nine polyclinics. In Australia, he was on the Board of the Royal Melbourne Hospital and the Victorian Comprehensive Cancer Centre, a $1billion project to create a fully integrated cancer care facility that brings together an integrated research, service and education offering to four million patients in Victoria.

Commenting on the appointment, Sir Richard Sykes, Chairman of NetScientific said: "Stephen's impressive leadership experience in mergers and commercialisation internationally further strengthens the Group. We look forward to welcoming Stephen to the team as we continue to build our subsidiary companies towards developing new technologies and concepts in healthcare management and diagnostics to improve patient care and outcomes."

Other than the information provided below, which is being disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies, there is no further information required to be disclosed pursuant to this rule. Stephen Kevin Smith, aged 64 years, has been a director of the following companies during the five years preceding the date of this announcement:

Current directorships	Past Directorships
StephenKSmith Ltd	London Genetics Limited
GNI (UK) Limited	The Nuffield Trust for Research and Policy Studies in Health Services
Metris Therapeutics Limited
I C Consultants Limited

- Ends -

Contact Details NetScientific François R. Martelet, M.D., CEO	Tel: [phone]
Investec (NOMAD and broker) Gary Clarence / Daniel Adams	Tel: [phone]
Instinctif Partners Melanie Toyne-Sewell / Jayne Crook / Rosanna Forrest	Tel: [phone] Email: [e-mail]

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment.

For more information, please visit the website at www.netscientific.net. 

 

END

 

 

BOADGGDDXGBBGLL